Merck will be making a $70 billion investment in U.S.-based research and manufacturing starting in 2025, the pharmaceutical company announced on Monday.

The company will begin its planned domestic investment by starting construction on a $3 billion pharmaceutical manufacturing site in Elkton, Virginia on Monday morning. The new site will employ over 500 full-time workers and create about 8,000 construction jobs within Virginia.

Recommended Stories

Trump IVF action gets restrained pushback from anti-abortion groups

Ohio parents could get more control over child’s medical records

Trump rolls out plan to lower costs of IVF and fertility care

As part of it’s $70 billion domestic investment over the next several years, Merck has announced four manufacturing projects across the United

See Full Page